Miles D. Chapman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Miles D. Chapman has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Edward J. Thompson
3 shared publicationsGavin Giovannoni
2 shared publicationsA.J. Church
1 shared publicationAndrew J. Church
1 shared publication- Axel Petzold
Moorfields Eye Hospital & UCL, London, UK
1 shared publication Clyde D. Wilson
1 shared publication
Latest Publications
- 1 April 2007
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 185 (1-2) , 130-135
Quantitative demonstration of intrathecal synthesis of high affinity immunoglobulin G in herpes simplex encephalitis using affinity-mediated immunoblotting
- 1 April 2007
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 185 (1-2) , 130-135
Quantitative demonstration of intrathecal synthesis of high affinity immunoglobulin G in herpes simplex encephalitis using affinity-mediated immunoblotting
- 24 January 2006
- Published by Elsevier in Journal of Immunological Methods
- Vol. 310 (1-2) , 62-66
Measurement of high affinity antibodies on antigen-immunoblots
- 24 January 2006
- Published by Elsevier in Journal of Immunological Methods
- Vol. 310 (1-2) , 62-66
Measurement of high affinity antibodies on antigen-immunoblots
- 1 May 2005
- Published by S. Karger AG in European Neurology
- Vol. 53 (2) , 81-83
Lack of Serum Oligoclonal Antibody Responses to Chlamydophila pneumoniae in Multiple Sclerosis
Chlamydophila pneumoniae has been proposed as an aetiological agent in MS via a mechanism involving molecular mimicry. We undertook to investigate whether the presence of CSF oligoclonal IgG OCB or oligoclonal bands correlated with serum IgG raised against C. pneumoniae. Paired serum and CSF of 19 MS patients and 27 control patients with other neurological diseases were studied by IEF and Western blotting. Only 1 of 19 MS patients had serum antibodies against C. pneumoniae compared with 2 of the 26 control patients. This was not significant, leading us to conclude that this study does not support the theory of an association between C. pneumoniae and MS.
- 1 May 2005
- Published by S. Karger AG in European Neurology
- Vol. 53 (2) , 81-83
Lack of Serum Oligoclonal Antibody Responses to Chlamydophila pneumoniae in Multiple Sclerosis
Chlamydophila pneumoniae has been proposed as an aetiological agent in MS via a mechanism involving molecular mimicry. We undertook to investigate whether the presence of CSF oligoclonal IgG OCB or oligoclonal bands correlated with serum IgG raised against C. pneumoniae. Paired serum and CSF of 19 MS patients and 27 control patients with other neurological diseases were studied by IEF and Western blotting. Only 1 of 19 MS patients had serum antibodies against C. pneumoniae compared with 2 of the 26 control patients. This was not significant, leading us to conclude that this study does not support the theory of an association between C. pneumoniae and MS.
- 27 December 2004
- Published by S. Karger AG in European Neurology
- Vol. 53 (1) , 27-31
No Evidence for Production of Intrathecal Immunoglobulin G against Acinetobacter or Pseudomonas in Multiple Sclerosis
The production of oligoclonal, polyspecific immunoglobulin G is characteristic of multiple sclerosis (MS), yet no pathogen has been identified as an infectious agent. Recent studies have proposed Acinetobactercalcoaceticus and Pseudomonas aeruginosa as candidate organisms, on the basis of a sequence homology between a bacterial enzyme and bovine myelin basic protein. To investigate this, we looked for specific, high-affinity immunoglobulin G against these pathogensin paired serum and cerebrospinal fluid from MS patients compared to other neurological diseases. We found no greater incidence of high-affinity antibodies against the organisms studied in MS vs. other neurological diseases, and so conclude that A. calcoaceticus and P. aeruginosa are unlikely to be implicated in the pathogenesis of MS.
- 27 December 2004
- Published by S. Karger AG in European Neurology
- Vol. 53 (1) , 27-31
No Evidence for Production of Intrathecal Immunoglobulin G against Acinetobacter or Pseudomonas in Multiple Sclerosis
The production of oligoclonal, polyspecific immunoglobulin G is characteristic of multiple sclerosis (MS), yet no pathogen has been identified as an infectious agent. Recent studies have proposed Acinetobactercalcoaceticus and Pseudomonas aeruginosa as candidate organisms, on the basis of a sequence homology between a bacterial enzyme and bovine myelin basic protein. To investigate this, we looked for specific, high-affinity immunoglobulin G against these pathogensin paired serum and cerebrospinal fluid from MS patients compared to other neurological diseases. We found no greater incidence of high-affinity antibodies against the organisms studied in MS vs. other neurological diseases, and so conclude that A. calcoaceticus and P. aeruginosa are unlikely to be implicated in the pathogenesis of MS.